Canadian Cancer Trials Group (CCTG) recognizes the value and importance of engaging patients, including the patient voice in all aspects of the clinical trial life-cycle. Integrating the patient perspective into the CCTG’s overall strategic agenda ensures the research agenda has the greatest impact on cancer patients in Canada and around the world.

CCTG has implemented a model of dedicated public and patient involvement by including the Patient Representative, who are patient volunteers recruited to disease site committees similar to academic committee members with a three year extendable term.

• The role of the CCTG Patient Representative has evolved to integrate the patient perspective into many steps of the research process with the aim of:
  • research questions that matter to patients, and
  • improved accrual
• CCTG is committed to implementing best practices and materials to foster and facilitate patient engagement

If you are looking for more information about the CCTG Patient Representative Committee please contact Yvonne Murray, Patient Engagement Lead for information.

CCTG is currently looking for volunteers for these roles:

• To support the Hematology Disease Site Committee | en français
• To support the Breast Disease Site Committee | en français 
• To support the Genito-Urinary Disease Site Committee | en français
• To support the Gynecologic Disease Site Committee | en français
• To support the Investigational New Drug (IND) Program | en francais

For more information about current committee openings please contact Nancy Dusharm.

CCTG Patient Representative Committee

Judy Needham - Patient Representative Chair

Bob Taylor

Carol Gordon

David McMullen

Erwin Wanderer

Janice Hodgson

Joan Petrie

Hilary Horlock

Catherine Wreford

Marie-Térèse Little

Martina Wood

 

Emi Bossio

Marg Redlick

Bill Richardson

Louise Bird

Jasmine Heuring

Haydn Bechthold

Suzanne Wood